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Abstract
CCL2 is a chemokine involved in brain inflammation, but the way in which it contributes to the entrance of lymphocytes in
the parenchyma is unclear. Imaging of the cell type responsible for this task and details on how the process takes place in
vivo remain elusive. Herein, we analyze the cell type that overexpresses CCL2 in multiple scenarios of T-cell infiltration in the
brain and in three different species. We observe that CCL2+ astrocytes play a part in the infiltration of T-cells in the brain and
our analysis shows that the contact of T-cells with perivascular astrocytes occurs, suggesting that may be an important
event for lymphocyte extravasation.
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Introduction
Lymphocyte infiltration is an important phenomenon in the
inflammatory response and is an event involved in many
degenerative scenarios of the CNS. Many brain tissue diseases,
such as brain tumors and viral or bacterial infections, among many
others, show infiltrated T-cell subsets. The effect of such T-cell
infiltration may vary in different CNS diseases, but controlling the
entrance of blood cells may have important clinical and
therapeutic implications. The phenomenon of extravasation is
regulated by a cascade of molecular events that involves the
adhesion of lymphocytes to the endothelium following their
migration into tissue [1,2,3]. Selectin-mediated interactions cause
lymphocytes to roll over the endothelial cells, at the same time
coming into contact different factors. The adhesion molecules
involved in the recruitment of lymphocytes into the tissue (such as
ICAM-1, VCAM or LFA-1) are well defined but less is known
about the factors that trigger the adhesion and direct the
extravasation. It has been proposed that chemokines or chemoat-
tractive cytokines trigger the adhesion and migration of lympho-
cytes either as soluble chemoattractants or as immobilized
molecules bound to proteoglycans of the endothelial surface [4].
CCL2 (formerly MCP-1) is one of the most important chemokines
involved in the recruitment of blood cells, especially macrophages
[5], into the tissues but fewer information is reported about its
effect on T lymphocytes. Significantly, CCL2 induces the
formation of the uropod in T-cells [1], a cellular formation crucial
for the cell’s entrance into the parenchyma. However, identifica-
tion of the brain cells in charge of this phase of extravasation in the
CNS and data on how the process takes place remain elusive. In
the present work we analyze the cellular expression of CCL2 in
three independent scenarios of T-cell infiltration in the brain in
vivo. We observe that the perivascular astrocytes highly express
CCL2, independently of the species and the inflammatory
situation, facilitating the entrance of lymphocytes into the brain.
CCL2-expressing astrocytes are specifically localized in the T-cell-
infiltration areas independently of the inflammatory scenario.
Importantly, blocking CCL2 attenuates the penetration of T-cell
infiltration in the brain, which suggests that CCL2 produced by
reactive astrocytes at the site of inflammation is responsible for T-
cell extravasation. On the other hand, the physical contact
between CCL2+ astrocytes and CD3+ T-cells takes place at
perivascular areas of the brain and we hypothesized that this
phenomenon may be important for lymphocyte internalization.
Materials and Methods
Patients and Samples
Fourteen patients from the General Hospital of Valencia (Spain)
were diagnosed with glioma of different degrees and were cited for
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intracranial surgery. The fourteen cases showed the typical
features of astrocytoma, with the classic clinical evolution,
neuroimaging, spectroscopy, and anatomo-pathological examina-
tion (Figure S1). The study was carried out according to the
approved protocols of all the institutions involved (General
Hospital of Valencia and University of Murcia). The approval
from the IRB of the University of Murcia was received regarding
the project (RYC-2010-06729) and a written informed consent
was obtained from all participants involved in the study (General
Hospital Permits # 07B0002707-09B0010238; University of
Murcia Project ID: RYC-2010-06729). The brain tumors
presented characteristic glioma morphology. Tumors were excised
and processed with a previously published protocol [6].
Adenovirally injected monkeys
All primate samples were collected for previously published
studies [7]. In the present work, we analyzed the brain tissue
sections from seven adult (either male or female) cynomolgus
monkeys (Macaca fascicularis) (5 kg body weight) that were
processed in preceding studies [7]. Briefly, the animals were
injected bilaterally with 16107 infective units of Ad-mCMV-bgal
adenovirus (Kindly provided by Dr. P.R. Lowenstein and Dr.
M.G. Castro) in six brain coordinates, including cortex and white
matter and the tissue was processed as described previously [7]. In
all studies involving non-human primates, all necessary steps were
taken to ameliorate any suffering or pain. The referenced study
was carried out according to the approved protocols of the
University of Murcia (Project ID: FEDER FD1/97-1931) and all
the experiments were conducted in accordance with the
Guidelines of the European Convention for the protection of
Vertebrate Animals used for Experimental and other scientific
purposes of the Council of Europe (nu 123, June 15th 2006).
Mice
Twenty-seven adult male C57BL6 mice were used to test the
role of CCL2 in the infiltration of lymphocytes in the brain.
Fourteen mice were used in a first experiment to analyze the
correlation between the infiltration of T-cells and the expression of
CCL2 cells after LPS injection. On day 0, mice were anesthetized
using ketamine (50 mg/kg) and medetomidine (1 mg/kg) and
either 2 mg/ml of LPS (n = 7) or saline (n = 7) in 1 ml of volume
was injected into the right striatum as previously described [8].
Four days were allowed to pass waiting for the immune response to
be stimulated. Then, animals were sacrificed on day 7, at the peak
of the potential T-cell response as has been previously described
[9]. On the other hand, in order to know the effect of CCL2 in the
lymphocyte infiltration, another experiment was performed
injecting goat anti-mouse CCL2 neutralizing antibody (R&D
Systems) directly into the brain parenchyma. Mice were
anesthetized and placed in the stereotactic frame and an injecting
guide cannula (Plastics One, C315G-SPC, Roanoke, VA, USA)
was placed in the right striatum in the same coordinates indicated
above. The guide cannula was then protected with a dummy
cannula (Plastics ONE, C315CD-SPC) following the instructions
of the manufacturers. After surgery, animals were left in their cage
for 15 days in order to eliminate/diminish the inflammation
caused by the intra-parenchymal placement of the cannula. After
this time, animals received an injection of LPS (2 mg/ml) using an
internal cannula (Plastics ONE, C3151-SPC), through the
previously implanted guided cannula, and four days later they
received, through the same cannula and with the help of a
microinjector, either an intraparenchymal injection of goat anti-
mouse CCL2 neutralizing antibodies (0.1 mg/ml, n = 3 or 1 mg/ml,
n = 5) or the purified isotype immunoglobulin (Goat IgG, 0.1 mg/
ml) on day 4th and 6th. Seven days after the LPS injection animals
were anesthetized and sacrificed and processed as described below.
Mice were anesthetized with an overdose of ketamine/xylacine
for perfusion-fixation (with PBS followed by 4% PFA). Brain tissue
was then removed and post-fixed in PFA for 48 hours. The study
was carried out according to the approved protocols of the
University of Murcia (Project ID: FIS/PI10/02827). All the
experiments were conducted in accordance with the Helsinki
Declaration, the Guide for the Care and Use of Laboratory
Animals (NIH Guide, revised 1996), the Guidelines of the
Europeanonvention for the protection of Vertebrate Animals used
for Experimental and other scientific purposes of the Council of
Europe (no 123, June 15th, 2006) and the European Communities
Council Directive 2010/63/ECC.
Immunocytochemical procedures
Brain tumor sections (60 mm) were selected according to the
anatomopathological criteria (Figure S1), cut serially through the
entire sample, and immunofluorescence or diaminobenzidine
(DAB) detection was performed as described previously [6].
Coronal monkey brain sections (50 mm) were cut serially through
the entire brain, and DAB detection or immunofluorescence was
performed as described previously [7]. In addition, hematoxilin
staining was performed in some of the sections to confirm the
localization of tumorigenic areas and blood vessels (BV). For
human or monkey tissue the following primary antibodies were
used: anti-human CCL2 (MCP-1) (1:40, mouse IgG2b; R&D),
anti-human CD3 (1:100, Rabbit or 1:50, Mouse, IgG1; Dako),
anti-human CD20 (1:500, mouse, IgG2a; Dako), anti-GFAP
(1:500, Rabbit; Chemicon), anti-LFA-1 (1:50, Rabbit; Abcam),
anti-human ICAM-1 (1:100, Mouse, IgG1; Sigma-Aldrich), anti-
human VCAM-1 (1:50, mouse, IgG1k; Dako), anti-CCR2 (1:200,
goat; Abcam) and Collagen-IV (1:500, Rabbit; Abcam). Mouse
brains were sectioned in 30 mm serial sections using a vibratome
(Leica), and were stained for immunofluorescence or DAB
detection using previously published protocols [8]. The following
antibodies were used: anti-mouse CCL2 (1:200, Rabbit, Serotec),
anti-mouse CD4 (1:750, Rat; Serotec), anti-mouse CD8 (1:750,
Rat; Serotec), anti-mouse CD3 (1:750, Hamster, Serotec) and anti-
GFAP (1:500; mouse, Chemicon, Millipore).
Quantification and sterological analysis
The number of labeled cells was quantified as previously described
[10]. CCL2+ cells and CD3+ T-cells were quantified in all species
studied. In mice, the number of CD4+ and CD8+ T-cells was also
counted. Correlations between the number of CCL2+ cells and the
number of CD3+ cells were calculated from the data obtained from
the quantifications of DAB+ immunostained sections. To obtain the
data for the correlations, two independents stereological quantifica-
tions of CD3 and CCL2 were performed in serial adjacent sections in
all specimens. Results were expressed as the mean 6 SEM.
Confocal imaging
Brain sections from human biopsies, monkey and mouse brain
were examined by confocal microscopy as described previously
[7]. Images are shown as the transparency of the stack of images or
showing a single 0.5 mm optical section.
Statistical analysis
Data are expressed as mean 6 SEM. Statistical analysis was
performed using student’s t-test or one-way ANOVA test following
a posthoc analysis. The null hypothesis was rejected for an a risk
equal to 5%.
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Results
All biopsies of patients with glioma presented high expression of
CCL2 in tumorigenic areas (Figure 1A). Importantly, all the cases
studied showed CCL2 immunoreactive cells, while the shape of the
areas of immunoreactivity differed according to the structure of the
tumor (Figure 1A, images 1–24). Areas far from the tumorigenic
center, putatively healthy tissue, did not show CCL2 immunore-
activity (Figure 1A, image 3) and a gradient of immunoreactivity
from non tumorigenic to tumorigenic areas could be clearly seen in
most cases (Figure 1A, image 10). CCL2 was especially high
around BVs’ lumen (Figure 1A, images 16–19 and 169–199) and
single cells showed star shape structures (Figure 1A, images 20–
24) similar to astrocyte-specific GFAP staining (Figure 1B). BVs,
inside and close to tumorigenic areas, strongly expressed CCL2, but
did not do so outside the tumorigenic areas (Figure 1C).
Importantly, confocal co-localization analysis revealed that astro-
cytes were the CCL2-expressing cells in the tumor area (Figure 2A).
These CCL2+ areas were seen to present the specific infiltration
of CD3+ T-cells in brain tumors (Figure 2B). However, in order
to understand the role of CCL2 in the specific extravasation of
CD3+ lymphocytes, the correlation between the number of tumor
infiltrating CD3+ T-cells and the number of expressing CCL2 cells
in the glioma samples was calculated. Importantly, we divided the
Figure 1. Human glioma shows CCL2+ cells. (A) The 14 cases of glioma analyzed show CCL2 expression in the tumorigenic areas. Samples of
gliomas were immunostained to detect the expression of CCL2. All 14 cases analyzed showed expression of CCL2 in the neoplasic areas. CCL2-
expressing cells are localized in the brain parenchyma itself and their number and intensity increase towards the necrotic areas. CCL2-expressing cells
can also be seen around BVs (16–19). In addition, counterstaining with hematoxilin is also shown at BV levels (169–199) to corroborate the presence of
endothelial nuclei. Insert show a detail of the endothelial nuclei. Scale bar; 1–21: 400 mm, 22–24: 60 mm. (B) Tumor cells present high
immunoreactivity for GFAP in tumor areas, demonstrating the typical astrocytic cell type. CCL2+ cells show a characteristic astrocytic morphology.
Scale bar: 30 mm. (C) BVs in, or close to the putative tumorigenic areas show high immunoreactivity for CCL2 in contrast to normal tissue.
Additionally, counterstaining with hematoxilin (HHS) is also shown at the same levels. The insert shows a detail of the endothelial nuclei. Scale bar:
100 mm.
doi:10.1371/journal.pone.0030762.g001
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T-cells into two different populations: T-cells inside the BV lumen
and those that were extravasated (Figure 2C). Interestingly, we
found that the amount of T-cells circulating in the BV lumen was
independent of CCL2 expression and no correlation was observed
(Figure 2D). Conversely, a significant correlation was seen
between the expression of CCL2 and the infiltration of T-cells
in the tumorigenic parenchyma (Figure 2D). These results
suggest that the presence of CCL2+ cells may be important for
the extravasation of lymphocytes, although a chemotactic effect of
secreted CCL2 into the blood circulation does not seem to
contribute to this phenomenon.
To investigate the role and cell type of CCL2 in other
inflammatory scenarios two animal experimental models of
inflammation and T-cell infiltration were studied, first using brain
Figure 2. CCL2+ cells are GFAP+ astrocytes in human glioma. (A) Confocal images show co-localization of CCL2-expressing cells (red) with
GFAP (green) in glioma. Insert shows a detail of a single CCL2-expressing cell (red) co-localizing with GFAP (green) and counterstained with DAPI
(blue). Scale bar: 30 mm. (B) Areas of infiltration of CD3+ T-cells (green) coincide with the areas of CCL2-expressing cells (red) in glioma. Confocal
images show a tumorigenic area, infiltrated with CD3+ T-cells (green) in an area with numerous CCL2-expressing cells (red). The immunostaining was
combined with a counterstaining with DAPI to detect the nucleus (blue). Scale bar: 50 mm. (C) Examples of characteristic CD3 infiltration in samples of
glioma. CD3+ T-cells can be observed grouped in BVs (BV, limited by broken red line in 1 and 3) but also infiltrated in the parenchyma (2, 4, blue insert
magnified in 5). (D) CCL2 expression correlates with the infiltration of T-cells in the tumor areas. The quantification in serial sections of the number of
T-cells, either infiltrated or located in the BV lumen, revealed that the level of infiltration of CD3+ T-cells in the parenchyma (green) is positively
correlated with the level of CCL2 expression (BV; BV lumen).
doi:10.1371/journal.pone.0030762.g002
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tissue from monkeys that had been infected stereotactically in the
cerebral cortex with artificially engineered adenoviral vectors.
Previous published analyses have shown that adenoviral injections
in the CNS elicit a specific infiltration of lymphocytes restricted to
the injection areas [7]. We analyzed the presence of lymphocytes
in the areas of injection, which were seen to express ICAM-1,
VCAM (Figures S2 and S3) in contrast with intact areas
(Figure S4). In addition, infiltrating lymphocytes express LFA-1
in the extravasation areas (Figure S5). Moreover, these areas of
viral injection showed a particular expression of CCL2 limited to
the injection area (Figure 3A). Importantly, confocal analysis of
the infiltrated areas showed highly immunoreactive CCL2-
expressing cells around BVs that were not present in intact (non-
injected) areas (Figure 3B, C and Figure S6). In addition,
detailed analysis of the virally injected areas demonstrated co-
localization of CCL2+ and GFAP+ cells (Figure 3D). Importantly,
the areas of CD3+ T-cell infiltration show CCL2 expressing cells
(Figure 3E) and a positive correlation was found between the
number of infiltrated CD3+ T-cells and the number of CCL2+ cells
in the adenoviral injected areas of monkey brain.
Figure 3. CCL2+ astrocytes are expressed in T-cell infiltration areas in monkey brain. (A) Immunofluorescence shows the specific CCL2
expression located at the area of adenoviral injection in the macaque brain. Drawing on the right shows the anatomical location of the stereotaxic
injection in the brain cortex. (B) Confocal images of BVs in an intact area and an injected area of the monkey brain. Perivascular astrocytes marked
with GFAP (green) show CCL2 expression (red) in the adenoviral-injected areas. DAPI (blue) was used as a nuclear counterstaining to show the
peculiar disposition of endothelial nuclei. (C) CCL2 is expressed by astrocytes in inflamed monkey brain. The staining of CCL2 (red) colocalizes with
the astrocyte marker GFAP (green) in monkey cortex in the adenovirally injected area. (D) Three dimensional transparency of an area of CD3+ T-cells
(green) infiltration shows specific CCL2 expression (magenta) in the brain of adenoviral injected monkey. DAPI was used as a counterstaining. Details
of the insert are shown in the images on the right. (E) The stereological quantification of serial adjacent sections demonstrated that the number of
infiltrated CD3+ cells correlates with CCL2+ cells in adenoviral injected areas in monkey brain.
doi:10.1371/journal.pone.0030762.g003
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Since CD3+ T-cells seem to respond to CCL2 in the inflamed
parenchyma in the human glioma and monkey brain, we analyze
their ability to express the CCL2 receptor (CCR2) in their cell
surface. We immuno-stained the glioma samples and monkey
brain sections with an antibody against CCR2 combined with
CD3 T-cell marker. Importantly, we observed that CD3+ T-cells
are able to express CCR2 in their surface (Figure 4), which makes
possible the interaction ligand-receptor in the extravasation
phenomenon. In addition, to rule out whether the immunoposi-
tivity for CCL2 in astrocytes might reflect the binding to CCR2,
we immunostained the sections with an antibody against CCR2
combined with the astrocytic marker GFAP. We observe that
CCR2 is not expressed in astrocytes (Figure S7) suggesting that
the immunopositivity for CCL2 in astrocytes does not correspond
to ligand binding to its receptor.
In order to further understand the functionality of CCL2 in
mediating T-cell infiltration into the brain parenchyma, we
induced brain inflammation with the stereotaxic injection of LPS
in the cortex and striatum of mice. After the LPS injection, we
observed a clear T-cell infiltration in the brain parenchyma
evidenced by the expression of T-cell markers, CD3, CD4 and
CD8 at the injection area (Figure 5A and B). The specific
infiltration of T-cells in the brain after LPS was observed
concomitantly with an increase in CCL2 expression limited to
the injected areas. In fact, we observed a significant positive
correlation between the number of infiltrated T-cells and the
number of CCL2+ cells (Figure 5B and Figure S8). Detailed
confocal co-localization analysis demonstrated that the CCL2+
cells were also astrocytes in LPS-induced infiltration in mice
(Figure 5C), similar to the situation observed in human gliomas
and monkey brain. These results suggest that CCL2-expressing
astrocytes may contribute to the T-cell infiltration into the brain
parenchyma. To better understand the intraparenchymal effect of
CCL2, we set up an experiment using an anti-CCL2 neutralizing
antibody, injected directly into the brain through an intracranial
cannula as described in detail in the methods section. Briefly, after
placing a guiding cannula in the mouse brain parenchyma, we
waited 15 days to allow the restoration of the inflammation caused
by the surgery (see diagram in Figure 5D). Then, we injected LPS
through the implanted guiding cannula to induce inflammation,
and after 4 days we injected either anti-CCL2 neutralizing
antibody or the specific immunoglobulin isotype as a control. The
histological analysis of the infiltration of CD4 and CD8 T-cells
revealed that the injection of anti-CCL2 reduces significantly the
infiltration of CD4+ and CD8+ lymphocytes (Figure 5D). This
infiltration is lowered with 0.1 mg/ml but it is significantly
diminished with 1 mg/ml which suggests a dose dependent effect
of the CCL2 neutralizing antibody administration. Taken
together, these results show that CCL2 functionally mediates the
extravasation of T-cells in mouse brain upon inflammation.
Our results suggest that CCL2-expressing astrocytes may
contribute to the specific extravasation of lymphocytes. Since
there is no correlation between CCL2+ astrocytes and T-cell
number in the lumen of the BV at the sites of inflammation, a
chemotactic effect of secreted CCL2 does not seem to contribute
to this phenomenon. Alternatively, CCL2-expressing astrocytes
might need to physically interact with T-cells in order to mediate
lymphocyte extravasation. To explore this possibility a detailed
high-resolution confocal analysis of the anatomical location of
infiltrating T-cells in the BVs and in the brain parenchyma of
inflammatory areas was carried out. Importantly, specific contacts
between CCL2+ cells and CD3+ lymphocytes were found in the
areas of infiltration (Figure 6A and B) and at the periphery of
BVs (Figure 6C), suggesting that the specific attachment of T-
cells to the perivascular astrocytes may be a crucial event in the
extravasation of T-cells in the inflamed brain (Figure 6D).
Discussion
In the present work, we show that, independently of the species
and of the CNS inflammatory scenario, the extravasation of
lymphocytes is mediated by CCL2-expressing astrocytes. In the
three inflammatory situations illustrated, we found a specific
increase of CCL2+ cells in the affected areas with a concomitant
T-cell infiltration. Importantly, our confocal images demonstrate
that perivascular astrocytes are responsible for the expression of
CCL2 in the three analyzed T-cell-infiltration situations in the
brain, in the three different species and with multiple antibodies
specific for CCL2. Our results demonstrate that the expression of
CCL2 by astrocytes contributes to the entrance of lymphocytes in
the brain parenchyma. In the experiments performed in mice, the
blocking of CCL2 by a specific neutralizing antibody attenuated
the infiltration of lymphocytes which suggests that CCL2,
expressed by astrocytes, contributes to the internalization of the
T-cells into the parenchyma. Furthermore, the fact that the level
of CCL2 expression correlates with the T-cell infiltration proper
and not with the number of lymphocytes circulating in the BVs,
strongly suggests that the presence of CCL2+ astrocytes contrib-
utes to the process of lymphocyte extravasation and play a part in
the cellular entrance. In addition, our data demonstrate that the
Figure 4. T cells express CCL2 receptor. Expression of CCR2 in T-cells in human glioma (top panel) and monkey brain (bottom panel). CD3+ T-
cells (green) express CCR2 in their surface (magenta). Nucleus is stained with DAPI (blue).
doi:10.1371/journal.pone.0030762.g004
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anatomical contact between lymphocytes and CCL2+ astrocytes
takes place in the internal wall of BV and we suggest that may
have a contributing role in the actual infiltration to the brain
parenchyma.
Our results also narrow down the controversy regarding the cell
type that is responsible of CCL2 expression in the brain. Previous
studies in biopsies of patients with multiple sclerosis and after brain
injury in mice have suggested that CCL2 is expressed by astrocytes
but no co-localization analysis of the proteins was conducted
[11,12]. In the present work, we show that CCL2 co-localizes with
GFAP in three different species, with two different antibodies, and
in three different situations of inflammatory-mediated lymphocyte
infiltration.
Importantly, in our study we hypothesize that the anatomical
apposition of T-cells and CCL2+ astrocytes may be an important
event in the internalization of lymphocytes in the brain
parenchyma. The CCL2 function was thought to be mainly
chemotactic, but our results suggest that the physical contact
between T-cells and astrocytes may also contribute to the actual
internalization into the brain parenchyma proper, probably after
the two phenomena of rolling and adhesion, which is coherent
with the induction of the uropod formation by CCL2 and
penetration through the endothelium, contributing to diapedesis
(Figure 6D).
From a therapeutic point of view, the manipulation of CCL2
may have beneficial effect in neurodegenerative diseases. CCL2
expression has been related with the aggressiveness of the glioma
[13] and, in fact, the use of CCL2 neutralizing antibodies has been
suggested as a possible strategy for their treatment [14]. However,
research into CCL2-mediated infiltration has mainly focused on
the role of tumor-infiltrated macrophages but not other cell types
[15]. Our present work suggests that, like macrophages, the CCL2
may also mediate lymphocyte infiltration in the glioma, and
contribute to the level of aggressiveness. In fact, in a previous
Figure 5. Intracerebral blocking of CCL2 attenuates the LPS-mediated T-cell infiltration. (A) Detail of CD4+ and CD8+ T-cell
immunostaining in the striatum of LPS injected mice. Scale bar: 20 mm. (B) The number of infiltrated T-cells (CD4+, CD8+ and CD3+ T-cells) correlates
with the number of CCL2+ cells in the areas of LPS injection. (C) Intraparenchymal injection of anti-CCL2 antibodies attenuates the LPS-induced
infiltration of lymphocytes in the mouse brain parenchyma. The diagram on the top shows the arrangement of the experiment. Graphs show the
density of CD8 and CD4 T-cells in the brain parenchyma surrounding the injection site. (D) Astrocytes express CCL2 after LPS injection in mouse brain.
Confocal images of the injected areas show the co-localization of GFAP+ astrocytes (green) and CCL2 (red) in mouse brain. DAPI (blue) was used as a
nuclear counterstaing. * p,0.05 ANOVA-test.
doi:10.1371/journal.pone.0030762.g005
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report, we demonstrated that T-cells infiltrate gliomas to contact
tumorigenic cells although a very low percentage shows cytolitic
features [6]. This suggests that the most tumor-infiltrated
lymphocytes are regulatory, reducing the activity of the cytolitic
cells and allowing the tumor to grow. Therefore, the manipulation
of CCL2 may be one of the particular therapeutic targets to
control the infiltration of lymphocytes in brain tumors. Accord-
ingly, in other neuroinflammatory processes, such as acute brain
Figure 6. T-cells come into contact with CCL2+ perivascular astrocytes in the areas of infiltration. (A) CCL2 is highly expressed in
perivascular astrocytes where T-cells infiltrate the brain tumor. Detailed confocal analysis of samples of gliomas revealed that tumorigenic areas show
CCL2-expressing astrocytes (red) with infiltration of CD3+ T-cells (green). Nuclei are stained with DAPI (blue). (B) Infiltration of T-cells occurs
throughout multiple anatomical contacts between T-cells and CCL2-expressing astrocytes. Image B1 shows numerous CD3+ T-cells (green)
establishing specific contacts with CCL2+ cells (red). In pictures B2, 3 and 4, a detail of T-cells (green) in contact with CCL2 perivascular astrocytes.
Image B4 shows a specific detail of a CD3/CCL2 contact on the xy axis and the two lateral views on the z axis. (C) Confocal analysis of a CD3+ T-cell
coming into contact with a CCL2+ cell located at the perivascular area of adenoviral injected monkey brain. The three dimensional transparency
(Composite) of a stack of images shows a CD3+ T-cell (green), in close apposition to the endothelium, marked with Col-IV (red), and contacting a
CCL2+ cell (magenta). A detail of the CD3-CCL2 contact is also shown in a 0.5 mm optical section on the xy axis and the two lateral views on the z axis.
(D) Diagram showing how T-cells may come into contact with CCL2-expressing astrocytes in the edge of BVs suggesting that CCL2+ astrocytes
contribute to the extravasation of T-cells in the brain parenchyma.
doi:10.1371/journal.pone.0030762.g006
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trauma, stroke, as well as during chronic affections like multiple
sclerosis or Alzheimer’s disease, prolonged and sustained inflam-
mation mediated by CCL2 may have cytotoxic effects, aggravating
the incidence and the severity of the disease [16]. Therefore,
targeting CCL2, more specifically in perivascular astrocytes, in
CNS inflammatory scenarios may be particularly important from
a therapeutic perspective.
Supporting Information
Figure S1 Tumors show typical anatomopathological
glioma characteristics. (A) Area of a sample of glioma with
hypercellular appearance with hemorragic areas. Insert shows
details of the marked hypercellularity. (B) Sample of a case of
glioma showing pleomorphic cells, aberrant mitosis and areas of
necrosis. Insert shows a detail of the pleomorhic cells and mitosis.
Necrosis area is indicated with an asterisk (*). (C) Sample of glioma
showing glomeruloid vessels (*), areas of necrosis (arrow) and
gemistocytic cells (Insert). (D) Sample of glioma showing
glomeruloid vessels (*). Insert shows a detail of a glomeruloid
vessel. Scale bars are indicated in each insert.
(TIF)
Figure S2 ICAM-1 expression in BVs in areas of
infiltration after viral injection in monkey brain. Top
panel shows over-expression of ICAM-1 (red) in perivascular
areas, where T-cells (green) infiltrate the brain parenchyma. DAPI
was used to stain the nuclei (blue). Bottom panel shows different
putative steps (from 1 to 6) of T-cell infiltration in the brain. (1, 2)
T-cells (green) rolling through the ICAM-1+ endothelial wall (red).
Picture 2 shows a rolling T-cell displaying a putative uropod (white
arrow). (3, 4) T-cells (green) in the adhesion process. (5, 6) T-cells
in the extravasation process.
(TIF)
Figure S3 VCAM-1 expression in BVs in areas of
infiltration after viral injection in monkey brain. Top
panel shows over-expression of VCAM-1 (red) in perivascular
areas, where T-cells (green) infiltrate in the brain parenchyma.
DAPI was used to stain the nuclei (blue). Bottom panel show a
detail of the area of infiltration.
(TIF)
Figure S4 Intact areas do not express ICAM-1 or VCAM-
1 in monkey brain. Confocal images of BV in intact areas of the
macaque brain. ICAM-1 and VCAM-1 are not over-expressed in
BV and no CD3+ T-cell infiltration is seen in non injected areas.
(TIF)
Figure S5 LFA-1 expression in lymphocytes in areas of
infiltration after viral injection in monkey brain. Top
panel shows over-expression of LFA-1 (magenta) in perivascular
areas, where T-cells (green) and B cells (red) infiltrate the brain
parenchyma. DAPI was used to stain the nuclei (blue). Bottom
panel shows a detail of the area of infiltration of T and B
lymphocytes co-localizing with LFA-1.
(TIF)
Figure S6 Staining of collagen-IV was performed to
unequivocally delineate blood vessels shown in figure 3B.
Confocal images show BVs in monkey brain sections stained with
DAPI (white) and collagen-IV (green). In the merged images DAPI
is shown in blue.
(TIF)
Figure S7 CCR2 is not expressed in GFAP+ astrocytes.
Immuno-staining of CCR2 in monkey brain and samples of
glioma combined with the astrocytic marker GFAP. (A) The areas
of adenoviral injection in monkey brain show CCR2+ cells
(magenta) and do not co-localize with GFAP marker (green).
DAPI was used as a counterstaining (blue). Insert shows contact
between a CCR2+ cell and a GFAP+ astrocyte. (B) Samples of
glioma (GBM1, GBM2 and GBM3) show CCR2+ cells (magenta)
and do not co-localize with GFAP+ astrocytes. DAPI was used as a
counterstaining (blue). Scale bars: 50 mm.
(TIF)
Figure S8 Increase in the number of CCL2+ cells in the
mouse brain after LPS intrastriatal injection. (A) Repre-
sentative picture of CCL2+ cells in the mouse striatum after LPS
injection compared to a saline injection. (B) Quantification of
CCL2+ cells in the injected striatum in a group of mice injected
with saline compared with a group of mice injected with LPS. A
dramatic increase of CCL2+ cells can be observed in the LPS
injected mice. *p,0.05 Student t-test.
(TIF)
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